Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Medtronic
Citi
Accenture
QuintilesIMS

Generated: May 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,998,402

« Back to Dashboard

Which drugs does patent 5,998,402 protect, and when does it expire?

Patent 5,998,402 protects DUAVEE and is included in one NDA.

This patent has forty-one patent family members in twenty-nine countries.

Summary for Patent: 5,998,402
Title: 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
Abstract:The present invention relates to new 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures below: ##STR1##
Inventor(s): Miller; Chris P. (Strafford, PA), Collini; Michael D. (Clifton Heights, PA), Tran; Bach D. (Media, PA), Santilli; Arthur A. (Havertown, PA)
Assignee: American Home Products Corporation (Madison, NY)
Application Number:08/833,271
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 5,998,402
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,998,402

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Wyeth Pharms DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 5,998,402

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 011503 ➤ Try a Free Trial
Austria 206701 ➤ Try a Free Trial
Australia 1892097 ➤ Try a Free Trial
Australia 710149 ➤ Try a Free Trial
Brazil 9701895 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
Federal Trade Commission
Queensland Health
Accenture
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.